We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

44 hedge funds and large institutions have $7.65M invested in BioPlus Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

156% more capital invested

Capital invested by funds: $2.99M → $7.65M (+$4.66M)

10% less funds holding

Funds holding: 49 → 44 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
8
Calls
$1.97M
Puts
–
Net Calls
+$1.97M
Net Calls Change
+$13K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$25.6K
2
MP
Mangrove Partners
Connecticut
+$18.9K
3
PC
Periscope Capital
Ontario, Canada
+$6.72K
4
LP
LMR Partners
United Kingdom
+$6.39K
5
CAC
Cowen and Company
New York
+$1.43K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$27K
2
RA
Ramius Advisors
New York
-$16K
3
MF
Magnetar Financial
Illinois
-$14K
4
AGM
Alpine Global Management
New York
-$5K
5
BCM
Basso Capital Management
Connecticut
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
26
Whitebox Advisors
Minnesota
$6.24K – – –
EFI
27
EHP Funds Inc
Canada
$6K -$618 -12,090 -9%
CCM
28
Context Capital Management
California
$5K – – –
Goldman Sachs
29
Goldman Sachs
New York
$4.99K – – –
PMAM
30
Picton Mahoney Asset Management
Ontario, Canada
$4K – – –
ACM
31
Atalaya Capital Management
New York
$3.75K – – –
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$3.45K – – –
Walleye Capital
33
Walleye Capital
New York
$3.19K – – –
DKCM
34
Davidson Kempner Capital Management
New York
$3K – – –
SFM
35
Spartan Fund Management
Canada
$3K – – –
YCM
36
Yakira Capital Management
Connecticut
$2.3K – – –
Walleye Trading
37
Walleye Trading
New York
$1.8K – – –
SAMU
38
SONA Asset Management (US)
New York
$1.5K – – –
RCM
39
Robinson Capital Management
Michigan
$1.46K – – –
COPPSERS
40
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1K – – –
OAC
41
OMERS Administration Corp
Ontario, Canada
$828 – – –
DCM
42
Dupont Capital Management
Delaware
$575 – – –
UBS Group
43
UBS Group
Switzerland
$2 +$6 +115 +115%
RA
44
Ramius Advisors
New York
– -$16K -196,073 Closed
UOC
45
UBS O'Connor
Illinois
– -$27K -187,997 Closed
MF
46
Magnetar Financial
Illinois
– -$14K -99,100 Closed
AGM
47
Alpine Global Management
New York
– -$5K -56,100 Closed
BCM
48
Basso Capital Management
Connecticut
– -$2K -25,000 Closed
USPCM
49
Union Square Park Capital Management
New York
– -$2K -25,000 Closed
WP
50
Woodline Partners
California
– -$2K -25,000 Closed
1
2
3

BIOSW Hedge Fund Activity: Q4 2022 in Review

44 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q4 2022, worth a combined $7.65M — up 156% from $2.99M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BIOSW and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $25.6K. The largest seller was UBS O'Connor, exiting entirely with an estimated $27K sold.

  • 44 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q4 2022, down from 49 in Q3 2022.
  • Funds reported $7.65M of BioPlus Acquisition Corp. Warrants stock for Q4 2022, up 156% quarter-over-quarter.
  • 3 funds opened new BioPlus Acquisition Corp. Warrants positions in Q4 2022 and 8 closed out, a net change of -5 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q4 2022 was Calamos Advisors, an estimated $25.6K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q4 2022 was UBS O'Connor, an estimated $27K sold.

Based on aggregated 13F filings for Q4 2022.